Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039728 | SCV000063417 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | 3502-8C>T in Intron 26 of PCDH15: This variant is not expected to have clinical significance because it has been identified in 0.7% (52/7020) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS). |
Eurofins Ntd Llc |
RCV000039728 | SCV000228482 | benign | not specified | 2015-01-02 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000407955 | SCV000363159 | uncertain significance | Usher syndrome type 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Gene |
RCV000761719 | SCV000717935 | benign | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000761719 | SCV000891904 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | PCDH15: BP4, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000039728 | SCV000919960 | benign | not specified | 2018-01-22 | criteria provided, single submitter | clinical testing | Variant summary: The PCDH15 c.3502-8C>T variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 1152/262912 control chromosomes (6 homozygotes), predominantly observed in the Ashkenazi Jewish subpopulation at a frequency of 0.008337 (83/9956). This frequency is about 3 times the estimated maximal expected allele frequency of a pathogenic PCDH15 variant (0.0031623), suggesting this is likely a benign polymorphism found primarily in the populations of Ashkenazi Jewish origin. The variant of interest has been reported in a study cohort of UK Usher patients, and was classified by authors as neutral (Le Quesne Stabej_2012). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign. |
Labcorp Genetics |
RCV000761719 | SCV001106855 | benign | not provided | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000761719 | SCV001144872 | benign | not provided | 2019-02-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000039728 | SCV001925616 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000761719 | SCV001968267 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826581 | SCV002094918 | benign | Usher syndrome type 1F | 2019-10-21 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004534843 | SCV004748102 | benign | PCDH15-related disorder | 2020-04-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |